Interaction of estrogen with central serotonergic mechanisms in human sensory processing: Loudness dependence of the auditory evoked potential and mismatch negativity

Journal of Psychopharmacology

Volumn 25, Issue 12, 2011, Pages 1614-1622

  Guille, Valérie ^a   Gogos, Andrea ^b,c   Nathan, Pradeep J ^d,e   Croft, Rodney J ^a,f   Van Den Buuse, Maarten ^b,c  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

5 HT1A receptors; auditory processing; estrogen; human; LDAEP; mismatch negativity; schizophrenia; serotonin

Indexed keywords

BUSPIRONE; ESTROFEM; SEROTONIN 1A RECEPTOR;

ADULT; ARTICLE; AUDITORY CORTEX; AUDITORY STIMULATION; BRAIN REGION; EVOKED AUDITORY RESPONSE; FEMALE; HEMISPHERE; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; LOUDNESS; MISMATCH NEGATIVITY; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; STIMULUS RESPONSE;

ADULT; BUSPIRONE; CONTINGENT NEGATIVE VARIATION; DOUBLE-BLIND METHOD; ESTROGENS; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; REACTION TIME; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 84856378840     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110370506     Document Type: Article

References (62)

1. Abi-Dargham A, Laruelle M, Aghajanian GK, Charney D, Krystal J. The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci. 1997 ; 9: 1-17 (Pubitemid 27075408)
2. Aghajanian GK, Marek GJ. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 1997 ; 36: 589-599 (Pubitemid 27272104)
3. Ahveninen J, Jaaskelainen IP, Osipova D, et al. Inherited auditory-cortical dysfunction in twin pairs discordant for schizophrenia. Biol Psychiatry. 2006 ; 60: 612-620 (Pubitemid 44402379)
4. Amargos-Bosch M, Bortolozzi A, Puig MV, et al. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex. 2004 ; 14: 281-299 (Pubitemid 38252721)
5. Anderer P, Saletu B, Saletu-Zyhlarz G, et al. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials. Neuropsychobiology. 2004 ; 49: 134-153 (Pubitemid 38420851)
6. Azmitia EC, Gannon PJ. The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv Neurol. 1986 ; 43: 407-468
7. Bantick RA, Deakin JF, Grasby PM. The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?. J Psychopharmacol. 2001 ; 15: 37-46 (Pubitemid 32242102)
8. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Brit J Med Psychol. 1974 ; 47: 211-218
9. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 2001 ; 156: 234-258 (Pubitemid 32705488)
10. Bramon E, Croft RJ, McDonald C, et al. Mismatch negativity in schizophrenia: a family study. Schizophr Res. 2004 ; 67: 1-10 (Pubitemid 38117086)
11. Carrillo-de-la-Peña MT. Effects of intensity and order of stimuli presentation on AEPs: an analysis of the consistency of EP augmenting/reducing in the auditory modality. Clin Neurophysiol. 1999 ; 110: 924-932 (Pubitemid 29281694)
12. Croft RJ, Barry RJ. EOG correction of blinks with saccade coefficients: a test and revision of the aligned-artefact average solution. Clin Neurophysiol. 2000 ; 111: 444-451 (Pubitemid 30123113)
13. Deouell LY, Bentin S, Giard MH. Mismatch negativity in dichotic listening: evidence for interhemispheric differences and multiple generators. Psychophysiology. 1998 ; 35: 355-365 (Pubitemid 28275369)
14. Fink BJ, Christensen MS. Bioavailability of oestradiol and oestriol administered orally to oophorectomized women. Maturitas. 1981 ; 3: 289-294 (Pubitemid 12145698)
15. Furuhjelm M, Karlgren E, Carlstrom K. The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand. 1984 ; 63: 655-661 (Pubitemid 15177583)
16. Gogos A, Nathan PJ, Guille V, Croft RJ, van den Buuse M. Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology. 2006 ; 31: 885-889
17. Gogos A, Van den Buuse M. Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-OH-DPAT. J Pharmacol Exp Ther. 2004 ; 309: 267-274 (Pubitemid 38393139)
18. Guille V, Croft RJ, O'Neill BV, Illic S, Phan KL, Nathan PJ. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacol. 2008 ; 23: 231-241 (Pubitemid 351577693)
19. Häfner H, Riecher-Rossler A, An Der Heiden W, Maurer K, Fatkenheuer B, Loffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med. 1993 ; 23: 925-940 (Pubitemid 23358453)
20. Hegerl U, Gaebel W, Gutzman H, Ulrich G. Auditory evoked potentials as possible predictors of outcome in schizophrenic outpatients. Int J Psychophysiol. 1988 ; 6: 207-214
21. Hegerl U, Gallinat J, Mrowinski D. Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol. 1994 ; 17: 1-13 (Pubitemid 24217848)
22. Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry. 1993 ; 33: 173-187 (Pubitemid 23089966)
23. Juckel G, Gallinat J, Riedel M, et al. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res. 2003 ; 64: 115-124 (Pubitemid 37412333)
24. Juckel G, Gudlowski Y, Muller D, et al. Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia-a replication study. Psychiatry Res. 2008 ; 158: 79-82
25. Juckel G, Hegerl U, Molnar M, Csépe V, Karmos G. Auditory evoked potentials reflect serotoninergic neural activity-a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology. 1999 ; 21: 710-716
26. Juckel G, Molnar M, Hegerl U, Csépe V, Karmos G. Auditory-evoked potentials as indicator of brain serotonin activity. First evidence in behaving cats. Biol Psychiatry. 1997 ; 41: 1181-1195 (Pubitemid 27237179)
27. Juckel G, Pogarell O, Augustin H, et al. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry. 2007 ; 68: 1206-1212 (Pubitemid 47395622)
28. Kähkönen S, Makinen V, Jaaskelainen IP, Pennanen S, Liesivuori J, Ahveninen J. Serotonergic modulation of mismatch negativity. Psychiatry Res. 2005 ; 138: 61-74 (Pubitemid 40228963)
29. Kasai K, Nakagome K, Itoh K, et al. Multiple generators in the auditory automatic discrimination process in humans. Neuroreport. 1999 ; 10: 2267-2271 (Pubitemid 29367921)
30. Khaliq F, Tandon OP, Goel N. Auditory evoked responses in postmenopausal women on hormone replacement therapy. Indian J Physiol Pharmacol. 2003 ; 47: 393-399 (Pubitemid 37151177)
31. Kulkarni J, Riedel A, de Castella AR, et al. Estrogen-a potential treatment for schizophrenia. Schizophr Res. 2001 ; 48: 137-144
32. Le Saux M, Di Paolo T. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene. J Psychiatry Neurosci. 2005 ; 30: 110-117 (Pubitemid 40769301)
33. Lechin F, van der Dijs B, Jara H, et al. Effect of buspirone on plasma neurotransmitters in healthy subjects. J Neural Transm. 1998 ; 105: 561-573 (Pubitemid 28454510)
34. Leung S, Croft RJ, Baldeweg T, Nathan PJ. Acute dopamine D1 and D2 receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. Psychopharmacology (Berl). 2007 ; 194: 443-451 (Pubitemid 47492996)
35. Levanen S, Ahonen A, Hari R, McEvoy L, Sams M. Deviant auditory stimuli activate human left and right auditory cortex differently. Cereb Cortex. 1996 ; 6: 288-296 (Pubitemid 26117404)
36. Lewis DA, Campbell MJ, Foote SL, Morrison JH. The monoaminergic innervation of primate neocortex. Hum Neurobiol. 1986 ; 5: 181-188
37. Lu NZ, Bethea CL. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology. 2002 ; 27: 12-24 (Pubitemid 34626739)
38. Michie PT. What has MMN revealed about the auditory system in schizophrenia?. Int J Psychophysiol. 2001 ; 42: 177-194 (Pubitemid 32928383)
39. Mitzdorf U. Current source-density method and application in cat cerebral cortex: investigation of evoked potentials and EEG phenomena. Physiol Rev. 1985 ; 65: 37-100 (Pubitemid 15165385)
40. Mize AL, Alper RH. Acute and long-term effects of 17β-estradiol on Gi/o coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPγS binding. Brain Res. 2000 ; 859: 326-333 (Pubitemid 30136105)
41. Mizuki Y, Suetsugi M, Ushijima I, Yamada M. Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity. Methods Find Exp Clin Pharmacol. 1994 ; 16: 291-300 (Pubitemid 24163897)
42. Näätänen R, Picton T. The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure. Psychophysiology. 1987 ; 24: 375-425 (Pubitemid 17114207)
43. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol. 2006 ; 21: 47-52 (Pubitemid 43192475)
44. Okazawa H, Yamane F, Blier P, Diksic M. Effects of acute and chronic administration of the serotonin 1A agonist buspirone on serotonin synthesis in the rat brain. J Neurochem. 1999 ; 72: 2022-2031 (Pubitemid 29186006)
45. O'Neill BV, Croft RJ, Leung S, et al. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology (Berl). 2006 ; 188: 92-99 (Pubitemid 44268245)
46. O'Neill BV, Croft RJ, Nathan PJ. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings. Hum Psychopharmacol. 2008a ; 23: 355-370
47. O'Neill BV, Guille V, Croft RJ, et al. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacol. 2008b ; 23: 301-312 (Pubitemid 351982667)
48. Oranje B, Jensen K, Wienberg M, Glenthøj BY. Divergent effects of increased serotonergic activity on psychophysiological parameters of human attention. Int J Neuropsychopharmacol. 2008 ; 11: 453-463 (Pubitemid 351744803)
49. Picton TW, Alain C, Woods DL, et al. Intracerebral sources of human auditory-evoked potentials. Audiol Neurootol. 1999 ; 4: 64-79 (Pubitemid 29054338)
50. Puig MV, Celada P, Diaz-Mataix L, Artigas F. In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cereb Cortex. 2003 ; 13: 870-882 (Pubitemid 36917967)
51. Scherg M, Picton TW. Separation and identification of event-related potential components by brain electric source analysis. Electroencephalogr Clin Neurophysiol Suppl. 1991 ; 42: 24-37
52. Scherg M, Von Cramon D. Evoked dipole source potentials of the human auditory cortex. Electroencephalogr Clin Neurophysiol. 1986 ; 65: 344-360 (Pubitemid 16048434)
53. Schroger E. Measurement and interpretation of the mismatch negativity. Behav Res Meth Instr Comp. 1998 ; 30: 131-145 (Pubitemid 128683397)
54. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull. 1990 ; 16: 185-194 (Pubitemid 20205356)
55. Thompson GC, Thompson AM, Garrett KM, Britton BH. Serotonin and serotonin receptors in the central auditory system. Otolaryngol Head Neck Surg. 1994 ; 110: 93-102 (Pubitemid 24054848)
56. Todd J, Michie PT, Schall U, Karayanidis F, Yabe H, Näätä nen R. Deviant matters: duration, frequency, and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia. Biol Psychiatry. 2007 ; 63: 58-64 (Pubitemid 350234882)
57. Umbricht D, Vollenweider FX, Schmid L, et al. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology. 2003 ; 28: 170-181
58. VanderMaelen CP, Matheson GK, Wilderman RC, Patterson LA. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur J Pharmacol. 1986 ; 129: 123-130 (Pubitemid 16033014)
59. Walpurger V, Pietrowsky R, Kirschbaum C, Wolf OT. Effects of the menstrual cycle on auditory event-related potentials. Horm Behav. 2004 ; 46: 600-606 (Pubitemid 39535141)
60. Wilson MA, Molliver ME. The organization of serotonergic projections to cerebral cortex in primates: retrograde transport studies. Neuroscience. 1991 ; 44: 555-570
61. Yadav A, Tandon OP, Vaney N. Auditory evoked responses during different phases of menstrual cycle. Indian J Physiol Pharmacol. 2002 ; 46: 449-456
62. Yokosuka M, Okamura H, Hayashi S. Transient expression of estrogen receptor-immunoreactivity (ER-IR) in the layer V of the developing rat cerebral cortex. Brain Res Dev Brain Res. 1995 ; 84: 99-108